Suicidal ideation is among the most serious symptoms of major depressive disorder and other psychiatric conditions
Suicidal Ideation Treatment in La Crosse, WI: Fast-Acting Help When the Pain Feels Unbearable
IV ketamine therapy and FDA-approved Spravato can reduce suicidal thoughts rapidly, often within 24 hours. For people whose depression has reached a point where waiting weeks for a medication to work isn't safe, these treatments offer a clinically validated, fast-acting alternative, right here in La Crosse.
You Haven't Run Out of Options. There Are Treatments That Work Faster Than You've Been Told.
Suicidal ideation, the experience of thoughts about ending one’s life, is one of the most serious symptoms of severe depression. It’s also one of the most urgent. When someone is experiencing suicidal thoughts, the weeks-long timeline of standard antidepressants isn’t just inconvenient. It’s clinically inadequate.
Ketamine therapy and Spravato work on a completely different neurological pathway than traditional antidepressants. Rather than slowly adjusting serotonin levels, they act on the brain’s glutamate system, producing rapid changes in neural connectivity that can reduce suicidal thoughts within hours to days. Spravato holds a specific FDA approval for major depressive disorder with active suicidal ideation or behavior, making it the only medication of its kind indicated for this combination.
At Relevate Ketafusion, we take suicidal ideation seriously and we move quickly. Our team offers compassionate, medically rigorous care for people whose depression has reached this level of severity, right here in La Crosse.


Understanding Suicidal Ideation: What It Is and Why Fast Treatment Matters
Suicidal ideation exists on a spectrum. Passive ideation involves thoughts about death or wishing to not be alive, without intent or planning. Active ideation involves thoughts of taking one’s own life, sometimes with specific plans or intent. Both require clinical attention, and both can be addressed with appropriate treatment.
Suicidal thoughts are most commonly associated with severe depression, but they can also arise in the context of PTSD, bipolar disorder, chronic pain, and other conditions that involve intense, persistent suffering. What connects these presentations is a sense that the pain won’t end, that there’s no other way out. Effective treatment changes that calculus by reducing the pain itself, rapidly.
The timeline of conventional antidepressants, which can take four to eight weeks to reach therapeutic effect, is a genuine clinical problem in the context of suicidal ideation. Ketamine and Spravato were developed in part to address exactly this gap. They don’t replace longer-term treatment, but they can create a window of relief that allows safer, more stable engagement with broader mental health care.
Hear from Those Who've Found Hope

Call us
(608) 518-3915Address
2309 State Road La Crosse, WI 54601
Working hours
Mon-Thu: 7:30 am - 7:30 pm
Fri-Sat: 7:30 am - 12:30 pm
Book Your Consultation
Fill out the form below, and we’ll contact you shortly.
Conditions That May Involve Suicidal Ideation That We Treat
Suicidal thoughts don't arise in a vacuum. They're a symptom of underlying conditions that need treatment. Ketamine therapy and Spravato address both the suicidal ideation and the conditions driving it.
Major Depressive Disorder with Suicidal Ideation
Spravato holds a direct FDA approval for major depressive disorder with active suicidal ideation or behavior, making it the first and only medication specifically indicated for this combination. For patients who are experiencing active suicidal thoughts alongside severe depression, Spravato offers a fast-acting, insurance-covered intervention that standard antidepressants simply can't match on timeline.
Treatment-Resistant Depression with Suicidal Ideation
When depression hasn't responded to multiple antidepressant trials and suicidal thoughts are present, the urgency is compounded. Both IV ketamine and Spravato were developed with treatment-resistant depression in mind and have demonstrated rapid anti-suicidal effects in clinical trials. For patients in this situation, ketamine therapy can provide a lifeline that bridges the gap while longer-term treatment strategies are developed.or antenatal depression develops during pregnancy and can be just as severe as PPD. Treatment during pregnancy requires careful clinical judgment, and our medical team, led by Dr. Howard Schumaker, approaches each case individually to determine the safest, most effective path forward.
PTSD with Suicidal Ideation
PTSD significantly elevates suicide risk, particularly in veterans and survivors of severe trauma. The combination of intrusive memories, emotional numbing, hypervigilance, and depression creates a burden that can feel impossible to carry. Ketamine therapy addresses both the PTSD symptoms and the depression that often accompanies them. Our team includes Lisa Knudtson, a Navy veteran and PMHNP who brings authentic understanding to this population.
Bipolar Depression with Suicidal Ideation
Bipolar disorder carries one of the highest suicide rates of any psychiatric condition, with suicidal ideation most commonly occurring during depressive episodes. For patients in a bipolar depressive episode with suicidal thoughts, carefully administered ketamine therapy can offer rapid relief. Our medical team screens thoroughly and monitors closely to ensure safe, appropriate treatment for bipolar presentations.
Chronic Pain with Suicidal Ideation
Chronic pain and suicidal ideation are closely linked. The relentless nature of uncontrolled pain, combined with the depression it frequently causes, can make suicidal thoughts feel like a rational response to an intolerable situation. Ketamine's dual ability to address both chronic pain and depression makes it particularly relevant for patients in this situation. Our chronic pain protocols can be discussed during your consultation.
Your Treatment Journey at Relevate Ketafusion
From your first conversation to your last session, we're with you at every step.
01
Initial Consultation
Your journey starts with a virtual consultation. We'll talk through your current situation, your diagnosis, your treatment history, and your goals. We'll be direct about what ketamine therapy can offer, how quickly it typically works, and what to expect. We understand the urgency that comes with suicidal ideation, and we move accordingly.
02
Personalized Treatment Plan
We build your plan around your specific diagnosis, clinical history, and level of urgency. We'll coordinate with your existing providers where appropriate and develop a treatment schedule that addresses the immediate crisis while laying the foundation for longer-term stabilization. We'll walk you through exactly what to expect at each stage.
03
Treatment Sessions
Every session takes place in a private, calm treatment room with continuous medical supervision. You're never alone. Our team monitors your vitals and your comfort in real time throughout every session. Most patients describe the experience as peaceful. Plan to have someone drive you home afterward.
04
Integration and Ongoing Monitoring
We monitor your response closely and adjust your plan as needed. The rapid relief that ketamine and Spravato provide creates a window in which engagement with therapy, support systems, and longer-term treatment becomes more possible. We work with you and your other providers to make the most of that window and build toward lasting stability.
Our Treatments for Suicidal Ideation: IV Ketamine and Spravato
We offer two clinically validated, rapid-acting treatments for suicidal ideation related to depression and other psychiatric conditions. Your provider will help determine the right fit based on your diagnosis, history, and the urgency of your situation.
IV Ketamine Therapy
Administered directly into the bloodstream through a small IV line, ketamine infusions offer precise dosing and immediate bioavailability. Sessions typically last 40 to 60 minutes in a private, calm treatment room with continuous medical supervision. Clinical research has shown meaningful reduction in suicidal ideation within 24 hours of the first infusion. IV ketamine is a self-pay treatment and not covered by insurance.
Learn More
Spravato (Esketamine) Therapy
FDA-approved specifically for major depressive disorder with active suicidal ideation or behavior, Spravato is administered as a nasal spray in our clinic under direct medical supervision, followed by a required monitoring period of approximately two hours. It's the only medication with this specific FDA indication, and it's covered by most major insurance plans. Our team handles insurance verification before your first visit.
Learn More
The Science Behind Ketamine for Suicidal Ideation
Standard antidepressants address suicidal ideation indirectly, by treating the underlying depression over a period of weeks. For many patients, this timeline is dangerous. Ketamine and Spravato take a different approach that produces results on a fundamentally different timeline.
Both treatments act on NMDA receptors and the glutamate system, triggering rapid synaptic growth and restoring neural connectivity in the prefrontal cortex, the region responsible for future thinking, problem-solving, and the ability to imagine alternatives to a painful present. Depression and suicidal ideation narrow this capacity profoundly. Ketamine helps reopen it, quickly.
The FDA’s approval of Spravato for MDD with active suicidal ideation followed rigorous Phase III clinical trials demonstrating its rapid efficacy. For IV ketamine, multiple clinical studies have confirmed meaningful reduction in suicidal ideation within 24 hours of the first infusion, a timeline that no other available medication can match.

Why Choose Relevate Ketafusion for Suicidal Ideation Treatment
01
Spravato's Specific FDA Approval for Suicidal Ideation
Spravato is the only FDA-approved medication specifically indicated for MDD with active suicidal ideation or behavior. It’s covered by most major insurance plans, and our team handles verification before your first visit. For patients in this situation, that specific indication and insurance coverage matters.
02
Rapid-Acting Relief When Speed Matters Most
Both IV ketamine and Spravato produce meaningful results within hours to days rather than weeks. When suicidal ideation is present, that timeline isn’t a feature. It’s a necessity. We understand the urgency of this situation and we treat it accordingly.
03
The Only IV Ketamine Clinic in the Coulee Region
Relevate Ketafusion is the only provider in the La Crosse area offering IV ketamine infusions. The nearest alternative is over two hours away. When someone needs help fast, distance is a barrier we’ve worked to eliminate.
04
Continuous Medical Supervision at Every Session
Every session happens under direct medical supervision with continuous monitoring. You’re never alone, and our team responds in real time throughout every visit. For patients navigating suicidal ideation, that level of attentiveness and safety is not optional.
05
A Team That Understands Trauma, Crisis, and What People Need to Heal
Dr. Howard Schumaker’s emergency medicine background gives him direct experience with crisis care. Lisa Knudtson, a Navy veteran and PMHNP, brings deep experience with the trauma and depression that drive suicidal ideation in veterans and first responders. Robyn Brown’s personal experience with anxiety grounds her approach in genuine empathy. This is a team that shows up for the hardest moments.
06
Founded by Someone Who Knows What Rock Bottom Looks Like and What Recovery Feels Like
Tina Schumaker built Relevate after her own experience with treatment-resistant depression and PTSD. She knows what it means to be in a place where hope is hard to find, and what it feels like when something finally works. That experience is the foundation of everything this clinic does.
Blogs
Insights & Resources
Explore articles that empower your path to wellness.

March 25, 2026
Hope Beyond Traditional Antidepressants: Exploring New Paths to Healing

March 18, 2026
The Role of Integration After Ketamine Sessions

March 11, 2026
Understanding Dissociation: Why Some People Experience It and How It Is Managed During Treatment